doxorubicin HCl liposome injection

DRUG3 trials

Sponsors

Telik, Sanofi

Conditions

Ovarian NeoplasmsSolid Tumors

Phase 3

TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer

CompletedNCT00057720

TelikOvarian Neoplasms

Start: 2003-06-30End: 2006-12-31Target: 440Updated: 2011-07-25

TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer

CompletedNCT00102973

TelikOvarian Neoplasms

Start: 2004-12-31End: 2008-07-31Updated: 2012-05-31

Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial

CompletedNCT01593228

SanofiSolid Tumors

Start: 2012-05-31End: 2016-09-30Updated: 2017-09-19